Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Children and Young Adults with Drug-Resistant Epilepsy
NCT02286986Phase 1Completed
- Sponsor
- University of Utah
- Start
- Sep 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in epilepsy comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Safety and Tolerability Profile at Day 7 and Proportion of Patients with >=50% Reduction in Convulsive Seizures at 60 days. Started Sep 2014; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02286986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286986.